Clinicometabolic profile of fatty liver disease in obese children: a study from Kashmir

Syed Basharat Ahmed; Ashfaq Masood; Bilal Ahmad Paul; Naiem Ur Rehman; Mushtaq A. Bhat; Zubair Mushtaq Tramboo; Javeed Iqbal Bhat; Bazila Jawaid

doi:10.18203/2349-3291.ijcp20254182

Authors

Syed Basharat Ahmed Department of Neonatology and Pediatrics, Sher I Kashmir Institute of Medical Sciences, Srinagar, India
Ashfaq Masood Department of Neonatology and Pediatrics, Sher I Kashmir Institute of Medical Sciences, Srinagar, India
Bilal Ahmad Paul Department of Neonatology and Pediatrics, Sher I Kashmir Institute of Medical Sciences, Srinagar, India
Naiem Ur Rehman Department of Neonatology and Pediatrics, Sher I Kashmir Institute of Medical Sciences, Srinagar, India
Mushtaq A. Bhat Department of Neonatology and Pediatrics, Sher I Kashmir Institute of Medical Sciences, Srinagar, India
Zubair Mushtaq Tramboo Department of Neonatology and Pediatrics, Sher I Kashmir Institute of Medical Sciences, Srinagar, India
Javeed Iqbal Bhat
Bazila Jawaid Department of Gynaecology and Obstetrics, Sher I Kashmir Institute of Medical Sciences, Medical College Srinagar, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20254182

Keywords:

Fatty liver, Obese children, FibroScan

Abstract

Background: Childhood obesity is an emerging public health challenge and is closely associated with metabolic abnormalities and hepatic complications, particularly fatty liver disease. Objectives were to assess the clinicometabolic profile and determine the incidence of fatty liver disease among overweight and obese children from Kashmir.

Methods: This descriptive cross-sectional study was conducted over two years from August 2022 to July 2024 at a tertiary care center. A total of 112 children aged 5-18 years with body mass index (BMI) ≥85^th percentile were enrolled. Anthropometry, blood pressure measurement, and biochemical evaluation including fasting glucose, lipid profile, liver enzymes, and thyroid function tests were performed. Hepatic steatosis was assessed by ultrasonography, and FibroScan was performed in children with significant ultrasonographic changes or persistent elevation of liver enzymes.

Results: The mean age was 10.29±2.71 years, with males constituting 57.1% of participants; 71.4% were obese (BMI ≥95^th percentile). Metabolic abnormalities were common, including impaired fasting glucose in 19.6%, hypertriglyceridemia in 73.2%, low HDL cholesterol, and elevated blood pressure in nearly one-third of children. Elevated AST and ALT levels were observed in 52.7% and 34.8% of participants, respectively. Ultrasonography detected fatty liver in 67.9% of children, with prevalence increasing with BMI. FibroScan revealed elevated controlled attenuation parameter values consistent with hepatic steatosis, while liver stiffness values remained within the F0-F1 range.

Conclusions: Fatty liver disease is highly prevalent among obese children and is strongly associated with metabolic derangements, emphasizing the need for early screening and comprehensive metabolic evaluation.

Metrics

Metrics Loading ...

References

Barry MP, Colleen MD. The obesity epidemic is a worldwide phenomenon. Nutrit Rev. 1998;56(4):106-14. DOI: https://doi.org/10.1111/j.1753-4887.1998.tb01722.x

Jacob JJ. Tackling the rising tide: Understanding the prevalence of childhood obesity in India. Indian J Endocrinol Metabol. 2024;28(2):101-3. DOI: https://doi.org/10.4103/IJEM.IJEM_144_24

Williams DP, Going SB, Lohman TG. Erratum: Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Publ Heal. 1992;82(4):527. DOI: https://doi.org/10.2105/AJPH.82.3.358

Child and teen BMI caregories; Centre for Disease Control and Prevention. 2024. Available at: http://www.cdc.gov. Accessed on 20 October 2025.

Flegal KM, Wei R, Ogden C. Weight-for-stature compared with BMI for age growth charts for the United States from the Centres for Disease Control and Prevention. Am J Clin Nutrit. 2002;75(4):761-6. DOI: https://doi.org/10.1093/ajcn/75.4.761

Himes JH, Dietz WH. Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. Am J Clin Nutrit. 1994;59(2):307-16. DOI: https://doi.org/10.1093/ajcn/59.2.307

Ghosh A. Explaining overweight and obesity in children and adolescents of Asian Indian origin: the Calcutta childhood obesity study. Indian J Publ Health. 2014;58(2):125. DOI: https://doi.org/10.4103/0019-557X.132290

Jain A, Jain A, Pankaj J. The study of obesity among children aged 5-18 years in Jaipur, Rajasthan. Muller J Med Sci Res. 2016;7(2):125-30. DOI: https://doi.org/10.4103/0975-9727.185013

Flodmark CE, Lissau I, Moreno LA, Pietrobelli A, Widhalm K. New insights into the field of children and adolescents‟ obesity: the European perspective. Int J Obesity. 2004;28(10):1189-96. DOI: https://doi.org/10.1038/sj.ijo.0802787

Clark JM, Brancati FL, Diehl AM. The prevalence and aetiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98(5):960-7. DOI: https://doi.org/10.1111/j.1572-0241.2003.07486.x

Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37(5):1202-19. DOI: https://doi.org/10.1053/jhep.2003.50193

Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413-9. DOI: https://doi.org/10.1016/S0016-5085(99)70506-8

Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, et al. Liver involvement in obese children. Dig Dis Sci. 1997;42(7):1428-32.

Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000;136(6):727-33. DOI: https://doi.org/10.1016/S0022-3476(00)24645-3

Tazawa Y, Noguchi H, Nishiomya F, Takada G. Serum alanine aminotransferase activity in obese children. Acta Paediatr. 1997;86(3):238-41. DOI: https://doi.org/10.1111/j.1651-2227.1997.tb08881.x

Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004;28(10):1257-63. DOI: https://doi.org/10.1038/sj.ijo.0802734

Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002;16(5):663-78. DOI: https://doi.org/10.1053/bega.2002.0333

Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis 2001;21(1):89-104. DOI: https://doi.org/10.1055/s-2001-12932

Chitturi S, George J. Interaction of iron, insulin resistance, and NASH. Curr Gastroenterol Rep 2003;5(1):18-25. DOI: https://doi.org/10.1007/s11894-003-0005-y

Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000;343(20):1467-76. DOI: https://doi.org/10.1056/NEJM200011163432007

Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr. 1997;24(3):317-21. DOI: https://doi.org/10.1002/j.1536-4801.1997.tb00431.x

Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of paediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143(4):500-5. DOI: https://doi.org/10.1067/S0022-3476(03)00325-1

Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology. 2002;36(2):403-9. DOI: https://doi.org/10.1053/jhep.2002.34738

Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Paediatrics. 2001;107(1):e13. DOI: https://doi.org/10.1542/peds.107.1.e13

Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during followup in an Italian population. Dig Dis Sci. 1997;42(7):1428-32. DOI: https://doi.org/10.1023/A:1018850223495

Chalasani N, Younossi Z, Lavine JE, Anna MD, Elizabeth MB, Kenneth C, et al. AASLD practice guidelines. The diagnosis and management of non-alcoholic fatty liver disease: practice guidelines by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-23. DOI: https://doi.org/10.1002/hep.25762

Al-Ghamdi AS. Fibroscan®: A noninvasive test of liver fibrosis assessment. Saudi J Gastroenterol. 2007;13(3):147-9. DOI: https://doi.org/10.4103/1319-3767.33470

Moran JR, Grisham FK, Halter SA, Greene HL. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol. 1983;78(6):374-7.

Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr. 1984;3(3):408-14. DOI: https://doi.org/10.1002/j.1536-4801.1984.tb08690.x

Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity: an epidemiological ultrasonographic survey. Dig Dis Sci. 1995;40(9):2002-9. DOI: https://doi.org/10.1007/BF02208670

Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004;24(1):3-20. DOI: https://doi.org/10.1055/s-2004-823098

Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202-9. DOI: https://doi.org/10.1016/j.jhep.2020.07.045

Hunter AK, Lin HC. Review of Clinical Guidelines in the Diagnosis of Pediatric Nonalcoholic Fatty Liver Disease. Clin Liver Dis (Hoboken). 2021;18(1):40-4. DOI: https://doi.org/10.1002/cld.1094